Back to Search
LARRY MORELAND, MD
MD
Rheumatology Physician
NPI: 1720019334IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
13197(AL)DR.0063871(CO)
Education
WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE
Class of 1983
Research & Publications (20)
Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value.
PMID 19644881·Arthritis Rheum·2009
8-other
Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors.
PMID 19681709·Clin Infect Dis·2009
5-case
Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms.
PMID 19022481·Semin Arthritis Rheum·2009
6-review
REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis.
PMID 19503088·Nat Genet·2009
8-other
Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: a 5-year extended phase IIB study.
PMID 19273451·J Rheumatol·2009
3-trial
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.
PMID 19333948·Arthritis Rheum·2009
3-trial
Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate.
PMID 18383390·Arthritis Rheum·2008
3-trial
Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study.
PMID 18759308·Arthritis Rheum·2008
3-trial
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease.
PMID 18512816·Arthritis Rheum·2008
4-observational
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.
PMID 18512708·Arthritis Rheum·2008
8-other
Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis.
PMID 18198196·Ann Rheum Dis·2008
4-observational
The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture.
PMID 18240241·Arthritis Rheum·2008
4-observational
Outcome measurements in scleroderma: results from a delphi exercise.
PMID 17299843·J Rheumatol·2007
8-other
Guidelines for assessing immunocompetency in clinical trials for autoimmune diseases.
PMID 17329169·Clin Immunol·2007
6-review
Interleukin-6 receptor antagonist as therapy for rheumatoid arthritis.
PMID 17969944·Curr Rheumatol Rep·2007
8-other
Disease modifiers: making the right therapeutic choices for our patients.
PMID 17611975·J Rheumatol Suppl·2007
5-case
Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options.
PMID 17393414·Arthritis Rheum·2007
6-review
Solvent-free synthesis and crystal structure of (Ph3PI)I5, the third member in the series Ph3P(I2)n (n = 1, 2 and 3).
PMID 17088637·Acta Crystallogr C·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12605 E 16TH AVE
AURORA, CO 80045 - Phone
- (720) 848-0000
Quick Facts
- NPI
- 1720019334
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile